Guideline / position statementindependent cross-checkfull text checked★ key study I-SOD-08 in-depth review

WHO on non-sugar sweeteners

WHO advises not to use non-sugar sweeteners for weight control in newly released guideline (Use of non-sugar sweeteners: WHO guideline, 2023) — news release

Overview

World Health Organization. WHO news release 2023

WHO advises not to use sweeteners for weight control, because no long-term benefit was shown; possible harms may be confounded.

Does the study support the specific claim? Partly · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Should NSS be used for weight control/NCD risk reduction?

How was the study done?

International guideline (news release read in full).

How many people, animals or samples were studied?

Not applicable; All people except those with pre-existing diabetes

What was actually found?

Recommends against NSS to control weight or reduce NCD risk; NSS confer no long-term benefit for body fat; potential undesirable effects (T2D, CVD, mortality) from long-term use; recommendation conditional because observed links might be confounded by baseline characteristics and complicated patterns of NSS use.

How large was the observed effect?

Not applicable

What do the results mean in everyday life?

Water or unsweetened drinks are preferable.

What are the study's limitations?

Conditional; observational evidence for harms

What does it say about Elawady's specific claim?

Supports C-SOD-10 (no proven benefit); limits C-SOD-06 (confounding).

Do the results apply to Germany and Europe?

Applies globally.

What can explicitly not be concluded from this study?

That sweeteners cause disease.

Scientific in-depth review

1. Full reference

Authors
World Health Organization
Journal
WHO news release
Year
2023
Identifier
Verification
verified – URL fetch 2026-10-25: https://www.who.int/news/item/15-05-2023-who-advises-not-to-use-non-sugar-sweeteners-for-weight-control-in-newly-released-guideline
Retracted
no
Corrections
none
Extent checked
full text
Conflicts of interest and funding

Not applicable

2. Research question

Should NSS be used for weight control/NCD risk reduction?

3. Study design and population

Study design
Guideline / position statement – International guideline (news release read in full).
Population

All people except those with pre-existing diabetes

Country

Global

Period

2023

Sample size

Not applicable

Inclusion and exclusion criteria

Based on a systematic review

4. Methods and endpoints

Exposure / intervention

NSS

Comparator

Free sugars/none

Endpoints

Body fat, T2D, CVD, mortality

Statistical methods

WHO guideline process

5. Actual results

Results

Recommends against NSS to control weight or reduce NCD risk; NSS confer no long-term benefit for body fat; potential undesirable effects (T2D, CVD, mortality) from long-term use; recommendation conditional because observed links might be confounded by baseline characteristics and complicated patterns of NSS use.

Absolute risks

not applicable

Authors' conclusion

Do not use NSS for weight control; reduce sweetness overall.

6. Strengths

  • Systematic review-based

7. Weaknesses

  • Conditional; observational evidence for harms

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable
Rationale

Guideline.

9. Assessment of the statistical interpretation

Not applicable.

10. Relevance to the specific claim

Supports C-SOD-10 (no proven benefit); limits C-SOD-06 (confounding).

11. Independent contrary findings

None.

12. Transferability to Germany and Europe

Applies globally.

13. Overall methodological judgement

Authoritative, cautious.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biasnot assessable
Precision of resultsnot applicable
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Long-term causal effects.

15. Linked fact checks